Changes in Renal Function in Congestive Heart Failure

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current Heart Failure Reports

• Publication date

  2013-10-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11897-013-0170-8PMID 24158384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiorenal Syndrome

  2020cited by this paper
• The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure

  2014cited by this paper
• Pathophysiology of the Cardiorenal Syndromes: Executive Summary from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)

  2014cited by this paper
• Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

  2013cited by this paper
• Abdominal contributions to cardiorenal dysfunction in congestive heart failure.

  2013cited by this paper
• Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

  2013cited by this paper
• Causes and treatment of oedema in patients with heart failure

  2013cited by this paper
• The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.

  2013cited by this paper
• Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference.

  2013cited by this paper
• Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations.

  2013cited by this paper
• Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.

  2013cited by this paper
• The Blood Urea Nitrogen to Creatinine Ratio Identifies a High Risk but Potentially Reversible Form of Renal Dysfunction in Patients with Decompensated Heart Failure

  2013cited by this paper
• Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury

  2013cited by this paper
• Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

  2013cited by this paper
• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

  2013cited by this paper
• Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.

  2013cited by this paper
• Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

  2013cited by this paper
• Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion.

  2013cited by this paper
• Within-person variability in kidney measures.

  2013cited by this paper
• The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment

  2012cited by this paper
• Changes in renal function after implantation of continuous-flow left ventricular assist devices.

  2012cited by this paper
• Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group

  2012cited by this paper
• The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

  2012cited by this paper
• Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

  2012cited by this paper
• KDIGO Clinical Practice Guidelines for Acute Kidney Injury

  2012cited by this paper
• Acute kidney injury and residual renal function

  2012cited by this paper
• Update in diuretic therapy: clinical pharmacology.

  2011cited by this paper
• Diuretic strategies in patients with acute decompensated heart failure.

  2011cited by this paper
• Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery) trial for CKD.

  2011cited by this paper
• Controlling the flood gates: vaptans, furosemide and the quest for a renal protective diuresis.

  2011cited by this paper
• Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).

  2011cited by this paper
• A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.

  2011cited by this paper
• The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.

  2011cited by this paper
• Effect of nesiritide in patients with acute decompensated heart failure.

  2011cited by this paper
• Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.

  2011cited by this paper
• Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decom

  2011cited by this paper
• Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure.

  2011cited by this paper
• Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study.

  2010cited by this paper
• Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival

  2010cited by this paper
• Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose Human ANP Infusion Therapy during cardiac surgery) for left ventricular dysfunction.

  2010cited by this paper
• Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

  2010cited by this paper
• Modulation of cGMP in heart failure: a new therapeutic paradigm.

  2009cited by this paper
• Cardio-Renal Effects of the A1 Adenosine Receptor Antagonist SLV320 in Patients With Heart Failure

  2009cited by this paper
• Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: a randomized controlled study.

  2009cited by this paper
• Background fluctuation of kidney function versus contrast-induced nephrotoxicity.

  2009cited by this paper
• Cardiorenal syndrome.

  2008cited by this paper
• The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.

  2008cited by this paper
• Blood urea nitrogen and serum creatinine: not married in heart failure.

  2008cited by this paper
• Circadian Variability of Cystatin C, Creatinine, and Glomerular Filtration Rate (GFR) in Healthy Men during Normal Sleep and after an Acute Shift of Sleep

  2008cited by this paper
• Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate.

  2008cited by this paper
• Renal effects of ularitide in patients with decompensated heart failure.

  2008cited by this paper
• Adenosine and kidney function: Potential implications in patients with heart failure

  2008cited by this paper
• Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity.

  2008cited by this paper
• Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.

  2008cited by this paper
• Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice.

  2008cited by this paper
• Removal of contrast medium from the coronary sinus during coronary angiography: feasibility of a simple and available technique for the prevention of nephropathy.

  2008cited by this paper
• Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

  2007cited by this paper
• Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

  2007cited by this paper
• Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

  2007cited by this paper
• Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial.

  2007cited by this paper
• Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

  2007cited by this paper
• Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.

  2007cited by this paper
• Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction

  2007cited by this paper
• Dual action of neutrophil gelatinase-associated lipocalin.

  2007cited by this paper
• Adenosine and kidney function.

  2006cited by this paper
• Cardiac biomarkers: a contemporary status report

  2006cited by this paper
• Haemodynamic and clinical effects of ularitide in decompensated heart failure.

  2006cited by this paper
• A novel contrast removal system from the coronary sinus using an adsorbing column during coronary angiography in a porcine model.

  2006cited by this paper
• Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

  2006cited by this paper
• Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.

  2005cited by this paper
• Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

  2004cited by this paper
• Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.

  2004cited by this paper
• Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

  2004cited by this paper
• Diuretic Therapy and Resistance in Congestive Heart Failure

  2002cited by this paper
• BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy

  2002cited by this paper
• Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

  2002cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

  2000cited by this paper
• Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.

  1999cited by this paper
• Hormones and hemodynamics in heart failure.

  1999cited by this paper
• Diuretic therapy.

  1998cited by this paper
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

  1997cited by this paper
• Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion.

  1995cited by this paper
• Renal interstitial pressure and sodium excretion during renal vein constriction.

  1980cited by this paper

• Extending the ambit of SGLT2 inhibitors beyond diabetes: a review of clinical and preclinical studies on non-diabetic kidney disease

  2021cites this paper
• Differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction-results of a meta-analysis of randomized controlled trials.

  2017cites this paper
• Clinical utility of single molecule counting technology for quantification of KIM-1 in patients with heart failure and chronic kidney disease.

  2017cites this paper
• Gambaran Kadar Kreatinin Serum Dan Lama Rawatan Pada Pasien Gagal Jantung Kongestif di RSUD Arifin Achmad Provinsi Riau Januari 2012 - Desember 2014

  2017cites this paper
• Type 4 cardiorenal syndrome.

  2016cites this paper
• Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure

  2016cites this paper
• The Impact Exerted on Clinical Outcomes of Patients With Chronic Heart Failure by Aldosterone Receptor Antagonists: A Meta-Analysis of Randomized Controlled Trials

  2016cites this paper
• Variability in inpatient serum creatinine: its impact upon short- and long-term mortality.

  2015cites this paper
• Estimación indirecta de la función renal y mortalidad por insuficiencia cardíaca: buscando el mejor predictor

  2014cites this paper